Era 1 · 1998–2005
Foundation & Defining the Niche
1998
1998
Company Founded
Launched as a specialist provider of regulatory and clinical writing services. Established core identity as a science-led, expert-driven organization.
1998–2001
First Major Client Engagements
Secured contracts with blue-chip pharma, delivering high-quality regulatory documents and strategic advice. Validated market need for specialized expertise.
2003
Core Quality Management System
Implementation of robust, scalable system for document control, SOPs, and quality assurance. Laid operational foundation for future growth.
2005
Trusted Partner Reputation
Track record of successful deliveries led to repeat business and referrals. Transitioned from vendor to trusted partner for early-stage companies.
Era 2 · 2006–2015
Strategic Expansion & Service Integration
2006
2008
Integrated Service Modules
Expansion beyond regulatory to include early-phase clinical operations and full regulatory strategy. Became comprehensive development ally.
2010
Cell & Gene Therapy Expertise
Early investment in understanding complexities of advanced therapies. Positioned NST as forward-thinking leader in high-growth sector.
2011
MHRA Assessment Passed
Successfully passed first MHRA assessment, demonstrating commitment to regulatory excellence and quality standards.
2012
MID-Frail Research Grant
Awarded first research grant (€5M) to conduct research into diabetes in elderly subjects, expanding into clinical research leadership.
2013
FRAILomic Research Grant
Awarded €7M research grant to identify markers and biomarkers of processes that turn frailty into disability.
2015
RASP-UK Research Grant
Awarded £5M (+match funding) to transform severe asthma diagnosis and management, paving way for new treatments.
Era 3 · 2016–2020
Brand Codification
2016
2016
Insider's Insights Launch
Released first Insider's Insight, receiving over 20,000 downloads and establishing thought leadership in the industry.
2019
'Biotech in a Box' Launch
Integrated service model formally branded as distinct offering for cost-efficient biotech and start-up partnering.
2020
20+ Years Celebration
Significant anniversary highlighting resilience, stability, and long-term client relationships. Reinforced message of trust and continuity.
2020
Brexit Adaptation
Rapid deployment of UK Legal Representation and MHRA gateway services for non-UK sponsors, demonstrating agility.
2020
COVID-19 Virtual Expansion
Went virtual and expanded globally. Demonstrated thought leadership, partnering with over 150 biotechs worldwide.
Era 4 · 2021–2025
The Agile Ally
2021
2022
SME Agility as Core Differentiator
Promoted ability to form expert teams in days, not months. Targeting pain points of slow, bureaucratic large CROs.
2023
Enhanced 'Biotech in a Box'
Further refinement with Dedicated Service Modules including Regulatory Gateway, Strategic Communications, and CGT support.
2024
25+ Year Legacy Milestone
Celebration of quarter-century of service. Positioned as mature, stable, and expert partner for high-stakes development.
Era 5: The Future · Into the future
Sustained Leadership and Evolution
Defining the geographic scalability of our Biotech in a Box Model, serving a global client base without sacrificing the personal partnership approach that has defined our success.
2026 →